Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP531185.RAbr-m1g852QwXwa-HuVRexm1RJGx3FJBhTq1WiM9Ar6g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP531185.RAbr-m1g852QwXwa-HuVRexm1RJGx3FJBhTq1WiM9Ar6g130_assertion type Assertion NP531185.RAbr-m1g852QwXwa-HuVRexm1RJGx3FJBhTq1WiM9Ar6g130_head.
- NP531185.RAbr-m1g852QwXwa-HuVRexm1RJGx3FJBhTq1WiM9Ar6g130_assertion description "[Twenty-one AIDS-related lymphomas, including five CD30-positive ALC and 11 small noncleaved cell (SNCC) lymphomas, and five Hodgkin's disease (HD) specimens were characterized regarding the immunophenogenotypic features, the frequency and subtype distribution of EBV (as defined by in situ hybridization [ISH], Southern blot, and a polymerase chain reaction [PCR] amplification of the EBV nuclear antigen-2 [EBNA-2] region) antigen expression (latent membrane protein-1 [LMP-1], EBNA-2, and for alterations of the tumor suppressor gene p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531185.RAbr-m1g852QwXwa-HuVRexm1RJGx3FJBhTq1WiM9Ar6g130_provenance.
- NP531185.RAbr-m1g852QwXwa-HuVRexm1RJGx3FJBhTq1WiM9Ar6g130_assertion evidence source_evidence_literature NP531185.RAbr-m1g852QwXwa-HuVRexm1RJGx3FJBhTq1WiM9Ar6g130_provenance.
- NP531185.RAbr-m1g852QwXwa-HuVRexm1RJGx3FJBhTq1WiM9Ar6g130_assertion SIO_000772 8617454 NP531185.RAbr-m1g852QwXwa-HuVRexm1RJGx3FJBhTq1WiM9Ar6g130_provenance.
- NP531185.RAbr-m1g852QwXwa-HuVRexm1RJGx3FJBhTq1WiM9Ar6g130_assertion wasDerivedFrom befree-20140225 NP531185.RAbr-m1g852QwXwa-HuVRexm1RJGx3FJBhTq1WiM9Ar6g130_provenance.
- NP531185.RAbr-m1g852QwXwa-HuVRexm1RJGx3FJBhTq1WiM9Ar6g130_assertion wasGeneratedBy ECO_0000203 NP531185.RAbr-m1g852QwXwa-HuVRexm1RJGx3FJBhTq1WiM9Ar6g130_provenance.